2022 update on prostate cancer epidemiology and risk factors—a systematic review
O Bergengren, KR Pekala, K Matsoukas, J Fainberg… - European urology, 2023 - Elsevier
Abstract Context Prostate cancer (PCa) is one of the most common cancers worldwide.
Understanding the epidemiology and risk factors of the disease is paramount to improve …
Understanding the epidemiology and risk factors of the disease is paramount to improve …
Epidemiology and prevention of prostate cancer
Abstract Context Worldwide, prostate cancer (PCa) represents the second most common
solid tumor in men. Objective To assess the geographical distribution of PCa …
solid tumor in men. Objective To assess the geographical distribution of PCa …
[HTML][HTML] Prostate cancer screening with PSA and MRI followed by targeted biopsy only
J Hugosson, M Månsson, J Wallström… - … England Journal of …, 2022 - Mass Medical Soc
Background Screening for prostate cancer is burdened by a high rate of overdiagnosis. The
most appropriate algorithm for population-based screening is unknown. Methods We invited …
most appropriate algorithm for population-based screening is unknown. Methods We invited …
[HTML][HTML] Prostate cancer incidence and mortality: global status and temporal trends in 89 countries from 2000 to 2019
Aims To evaluate current status of prostate cancer incidence and mortality worldwide, and
compare the global trends of incidence and mortality in the past two decades and in the …
compare the global trends of incidence and mortality in the past two decades and in the …
Molecular imaging in oncology: Current impact and future directions
The authors define molecular imaging, according to the Society of Nuclear Medicine and
Molecular Imaging, as the visualization, characterization, and measurement of biological …
Molecular Imaging, as the visualization, characterization, and measurement of biological …
EAU-EANM-ESTRO-ESUR-SIOG guidelines on prostate cancer. Part II—2020 update: treatment of relapsing and metastatic prostate cancer
P Cornford, RCN van den Bergh, E Briers… - European urology, 2021 - Elsevier
Objective To present a summary of the 2020 version of the European Association of Urology
(EAU)-European Association of Nuclear Medicine (EANM)-European Society for …
(EAU)-European Association of Nuclear Medicine (EANM)-European Society for …
Prostate-specific antigen testing as part of a risk-adapted early detection strategy for prostate cancer: European Association of Urology position and recommendations …
Background Recommendations against prostate-specific antigen (PSA) testing in 2012 have
increased advanced-stage diagnosis and prostate cancer–specific mortality rates. Objective …
increased advanced-stage diagnosis and prostate cancer–specific mortality rates. Objective …
[HTML][HTML] Management of patients with advanced prostate cancer. Part I: intermediate-/high-risk and locally advanced disease, biochemical relapse, and side effects of …
Background Innovations in imaging and molecular characterisation and the evolution of new
therapies have improved outcomes in advanced prostate cancer. Nonetheless, we continue …
therapies have improved outcomes in advanced prostate cancer. Nonetheless, we continue …
Serum PSA-based early detection of prostate cancer in Europe and globally: past, present and future
In the pre-PSA-detection era, a large proportion of men were diagnosed with metastatic
prostate cancer and died of the disease; after the introduction of the serum PSA test …
prostate cancer and died of the disease; after the introduction of the serum PSA test …
[HTML][HTML] Management of patients with advanced prostate cancer—metastatic and/or castration-resistant prostate cancer: report of the Advanced Prostate Cancer …
Background Innovations in imaging and molecular characterisation together with novel
treatment options have improved outcomes in advanced prostate cancer. However, we still …
treatment options have improved outcomes in advanced prostate cancer. However, we still …